Annual EBITDA
-$30.18 M
-$12.29 M-68.68%
December 31, 2023
Summary
- As of March 13, 2025, UNCY annual EBITDA is -$30.18 million, with the most recent change of -$12.29 million (-68.68%) on December 31, 2023.
- During the last 3 years, UNCY annual EBITDA has fallen by -$28.16 million (-1393.96%).
- UNCY annual EBITDA is now -1393.96% below its all-time high of -$2.02 million, reached on December 31, 2020.
Performance
UNCY EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$3.96 M
-$13.83 M-140.10%
September 30, 2024
Summary
- As of March 13, 2025, UNCY quarterly EBITDA is -$3.96 million, with the most recent change of -$13.83 million (-140.10%) on September 30, 2024.
- Over the past year, UNCY quarterly EBITDA has increased by +$3.74 million (+48.58%).
- UNCY quarterly EBITDA is now -140.10% below its all-time high of $9.87 million, reached on June 30, 2024.
Performance
UNCY Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$22.44 M
+$278.00 K+1.22%
September 30, 2024
Summary
- As of March 13, 2025, UNCY TTM EBITDA is -$22.44 million, with the most recent change of +$278.00 thousand (+1.22%) on September 30, 2024.
- Over the past year, UNCY TTM EBITDA has increased by +$7.74 million (+25.63%).
- UNCY TTM EBITDA is now -6462.28% below its all-time high of -$342.00 thousand, reached on March 31, 2020.
Performance
UNCY TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
UNCY EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.7% | +48.6% | +25.6% |
| 3 y3 years | -1394.0% | +48.6% | +25.6% |
| 5 y5 years | -1389.5% | +48.6% | +25.6% |
UNCY EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -221.9% | at low | -140.1% | +80.8% | -139.4% | +38.2% |
| 5 y | 5-year | -1394.0% | at low | -140.1% | +80.8% | -6462.3% | +38.2% |
| alltime | all time | -1394.0% | at low | -140.1% | +80.8% | -6462.3% | +38.2% |
Unicycive Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.96 M(-140.1%) | -$22.44 M(-1.2%) |
| Jun 2024 | - | $9.87 M(-147.8%) | -$22.72 M(-37.4%) |
| Mar 2024 | - | -$20.66 M(+168.4%) | -$36.32 M(+20.3%) |
| Dec 2023 | -$30.18 M(+68.7%) | -$7.70 M(+81.7%) | -$30.18 M(+8.7%) |
| Sep 2023 | - | -$4.24 M(+13.6%) | -$27.77 M(-4.4%) |
| Jun 2023 | - | -$3.73 M(-74.3%) | -$29.04 M(+0.5%) |
| Mar 2023 | - | -$14.52 M(+174.8%) | -$28.91 M(+61.6%) |
| Dec 2022 | -$17.89 M | -$5.28 M(-4.2%) | -$17.89 M(+16.6%) |
| Sep 2022 | - | -$5.51 M(+53.3%) | -$15.35 M(+2.5%) |
| Jun 2022 | - | -$3.60 M(+2.8%) | -$14.98 M(+23.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.50 M(+27.7%) | -$12.16 M(+29.7%) |
| Dec 2021 | -$9.38 M(+364.2%) | -$2.74 M(-46.8%) | -$9.38 M(+27.5%) |
| Sep 2021 | - | -$5.15 M(+560.6%) | -$7.35 M(+159.5%) |
| Jun 2021 | - | -$779.00 K(+9.4%) | -$2.83 M(+18.5%) |
| Mar 2021 | - | -$712.00 K(-0.7%) | -$2.39 M(+18.3%) |
| Dec 2020 | -$2.02 M(-0.3%) | - | - |
| Dec 2020 | - | -$717.00 K(+14.5%) | -$2.02 M(+55.0%) |
| Sep 2020 | - | -$626.00 K(+86.3%) | -$1.30 M(+92.3%) |
| Jun 2020 | - | -$336.00 K(-1.8%) | -$678.00 K(+98.2%) |
| Mar 2020 | - | -$342.00 K | -$342.00 K |
| Dec 2019 | -$2.03 M | - | - |
FAQ
- What is Unicycive Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Unicycive Therapeutics?
- What is Unicycive Therapeutics annual EBITDA year-on-year change?
- What is Unicycive Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Unicycive Therapeutics?
- What is Unicycive Therapeutics quarterly EBITDA year-on-year change?
- What is Unicycive Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Unicycive Therapeutics?
- What is Unicycive Therapeutics TTM EBITDA year-on-year change?
What is Unicycive Therapeutics annual EBITDA?
The current annual EBITDA of UNCY is -$30.18 M
What is the all time high annual EBITDA for Unicycive Therapeutics?
Unicycive Therapeutics all-time high annual EBITDA is -$2.02 M
What is Unicycive Therapeutics annual EBITDA year-on-year change?
Over the past year, UNCY annual EBITDA has changed by -$12.29 M (-68.68%)
What is Unicycive Therapeutics quarterly EBITDA?
The current quarterly EBITDA of UNCY is -$3.96 M
What is the all time high quarterly EBITDA for Unicycive Therapeutics?
Unicycive Therapeutics all-time high quarterly EBITDA is $9.87 M
What is Unicycive Therapeutics quarterly EBITDA year-on-year change?
Over the past year, UNCY quarterly EBITDA has changed by +$3.74 M (+48.58%)
What is Unicycive Therapeutics TTM EBITDA?
The current TTM EBITDA of UNCY is -$22.44 M
What is the all time high TTM EBITDA for Unicycive Therapeutics?
Unicycive Therapeutics all-time high TTM EBITDA is -$342.00 K
What is Unicycive Therapeutics TTM EBITDA year-on-year change?
Over the past year, UNCY TTM EBITDA has changed by +$7.74 M (+25.63%)